BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Ingen Technologies, Inc. (IGTN) Receives Confirmation of Purchase Order for Approximately 8,000 Oxyview(R) Units Valued at Approximately $160,000


8/8/2012 9:19:26 AM

RIVERSIDE, CA--(Marketwire - August 07, 2012) - Ingen Technologies, Inc. (PINKSHEETS: IGNT), an emerging medical device manufacturer with proprietary medical products for the growing $4B respiratory markets, announced today that the company has agreed to deliver approximately 8,000 Oxyview units in value of $160,000.

The first purchase order will include the reuseable Oxyview oxygen flow meter model 203A and 206A; and the disposable adult-size Smart Nasal Cannula. The company currently has 80,000 units in stock and will meet demands from the National Distributor over the next few months. Ingen has the manufacturing processes and tooling capabilities to produce 100,000 Oxyview units on a monthly basis, in value of $2M.

"In the US alone, there are over 30 million patients diagnosed with Chronic Obstructive Pulmonary Disease, and the majority of these patients require home oxygen therapy. The disposable Smart Nasal Cannula and the Oxyview will be introduced to the majority of these patients through the national distributor and large medical service providers," stated Gary Tilden, Chairman.

WATCH THE PRODUCT VIDEO TO LEARN ABOUT OXYVIEW: www.otcfn.com/ignt/

FOR MORE UPDATED INFORMATION USE THE FOLLOWING LINK: www.otcfn.com/ignt/

LISTEN TO INGEN'S CHAIRMAN INTERVIEW AT: http://smallcapvoice.com/blog/7-24-12-smallcapvoice-interview-with-ingen-technologies-inc-pink-sheets-ignt

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.


Contact:
Gary Tilden
951-688-7840
www.ingen-tech.com
Email Contact



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES